Common questions about Ascabiol (FAQ)
Q: How is Ascabiol different from prescription treatments like Permethrin or Ivermectin?
Official product information describes the Lindane component in some formulations as an organochloride insecticide. This active substance works by disrupting the parasites' nervous system by blocking their chloride channels. Ascabiol is sometimes unique due to the addition of Cetrimide, which provides antiseptic properties alongside the anti-parasitic action, contrasting with single-agent treatments.
Q: Why is it common to experience a burning or stinging sensation after applying Ascabiol?
Regulatory safety documents list a transient burning sensation as a commonly reported local effect. This skin reaction is an expected response to the product's formulation. It is generally described as a transient and common skin reaction.
Q: What is 'post-scabies itching' and what causes it to persist?
This is persistent itching that is known to occur following a successful parasitic treatment. Regulatory safety information notes that this feeling may persist for one to several weeks after the treatment course. The itching is generally related to the body's continuing immune or inflammatory response to the debris and dead parasites left in the skin.
Q: Should other topical products, like moisturizers or steroid creams, be avoided during treatment with Ascabiol?
Regulatory warnings advise caution against using oil treatments, oil-based hair dressings, and conditioners immediately before or after application. These products can enhance the systemic absorption of the active ingredient through the skin. This enhanced absorption can increase the risk of adverse effects.
Q: Why is the application of Ascabiol generally restricted to the neck down (for adults)?
Official instructions specify application to the entire body, excluding the head and face. This restriction helps minimize the risk of the product entering sensitive areas, like the eyes and mucous membranes. It is also intended to reduce the potential for systemic absorption in highly permeable areas like the face and scalp, which carries neurotoxicity risks.
Q: Why is it generally advised to avoid applying Ascabiol to the face and scalp?
Regulatory warnings state that applying the product to the head, face, or sensitive membranes (eyes/mouth) should be avoided. This is done to prevent irritation and to minimize the risk of systemic absorption. The active ingredient can affect the central nervous system if too much is absorbed through the skin.
Q: Is it necessary to clean the skin with a specific type of soap before applying the lotion?
Official instructions recommend that the skin should be washed and dried thoroughly before the emulsion is applied. However, regulatory guidance does not explicitly specify a requirement for a particular type of soap or cleanser to be used.
Q: What is the chemical function of Benzyl Benzoate as described in official sources?
Official regulatory sources classify Benzyl Benzoate as an acaricide and insecticide. Its role is to act as a neurotoxin on the targeted parasites. This action disrupts the organisms' nervous systems, leading to paralysis and eventual death.
Q: Can Ascabiol interact with prescription topical medications that are already being used on the skin?
Regulatory warnings advise caution against using any substances that are known to enhance skin absorption (such as oil-based products) before or after application. The intent of this caution is to minimize the systemic exposure of the active ingredients, which could happen if used with other permeability-enhancing products.
Q: Does Ascabiol kill the eggs of mites and lice, or just the adult parasites?
The mechanism of action is primarily designed to target the nervous system of the adult mites and lice. Official texts on the active components indicate that while the product is effective against the living parasites, its ovicidal (egg-killing) activity can be low or inconsistent.
Q: What is the guidance on accidental contact with Ascabiol in the eyes, mouth, or mucous membranes?
Official instructions emphasize that the product must not be allowed to come into contact with the eyes or mucous membranes because it can cause irritation. Regulatory guidance describes actions for accidental contact, indicating the affected area should be flushed immediately and thoroughly with water.
Q: Does the efficacy of Ascabiol lessen if the product is close to its expiry date?
Expiration dates are set under regulatory oversight to ensure the product retains its full strength, quality, and purity when stored correctly. Regulatory guidance warns that medication used after the expiry date may have a lower strength and may not provide the intended therapeutic benefit.
Q: What is the guidance on treating close contacts or family members who do not show symptoms?
Official public health guidance requires the identification of close contacts. Recommendations generally state that all identified contacts, even if asymptomatic, are generally recommended to receive coordinated treatment to interrupt the potential cycle of transmission.
Q: How does the concentration of the active ingredient in Ascabiol vary across different formulations or regions?
The product is available in different regional formulations based on local health authority approval. Common versions include a Benzyl Benzoate 25% w/v emulsion or a combination product containing 1% w/v Lindane and 0.1% w/v Cetrimide.
Q: What is the risk of developing an allergic reaction to Ascabiol's ingredients?
Regulatory documentation includes known hypersensitivity to the ingredients as a formal contraindication for use. This means that individuals with a known allergy or sensitivity to any component are formally restricted from using the product.
